Reported about 16 hours ago
Healthcare stocks are on the rise, with CRISPR Therapeutics and BioNTech emerging as strong contenders for further growth. CRISPR has promising gene-editing therapies in development, while BioNTech is advancing its oncology pipeline, including a potential competitor to the successful Keytruda. Despite market fluctuations, both companies hold significant potential for investors as they progress their innovative treatments.
Source: YAHOO